In Q4 2023, Boxer Capital held 43 positions worth $1.6B. They initiated 3 new positions and exited 33. Their largest holding was CYTK ($175.3M). Portfolio value grew +5.4% versus the prior quarter.
Frequently asked questions
What stocks did Boxer Capital own in Q4 2023?
Boxer Capital held 43 biotech stocks in their 13F portfolio in Q4 2023. Their top positions include CYTK, SWTX, RVMD, APLS, BEIGF. The full holdings table is available on BiotechEdge with position sizes, quarter-over-quarter changes, and AI analysis.
How much was Boxer Capital's portfolio worth in Q4 2023?
Boxer Capital's tracked biotech portfolio was worth $1.6B across 43 positions, with total assets under management of approximately $0.5B. Portfolio values are based on 13F filings with the SEC.
What did Boxer Capital buy in Q4 2023?
Boxer Capital initiated 3 new positions in Q4 2023, including GPCR, NKTX, SYRE. They also increased 7 existing positions.
What did Boxer Capital sell in Q4 2023?
Boxer Capital fully exited 33 positions in Q4 2023, including COGT, CGEM, MRSN, NRIX, PMVP and 28 more. They also trimmed 4 existing positions.
Is Boxer Capital a biotech fund?
San Diego-based biotech specialist investing across the full drug development lifecycle from preclinical through commercial. Takes concentrated positions with deep scientific due diligence, leveraging proximity to the Southern California biotech cluster.
Want AI analysis, insider signals, and catalyst overlays for Boxer Capital?
View latest Boxer Capitalportfolio →